Théodore J. Lampidis

A phase I dose-escalation trial of 2-deoxy-d-glucose alone or combined with docetaxel in patients with advanced solid tumors

Luis E. Raez, Kyriakos P. Papadopoulos, Alejandro D. Ricart et al. · Cancer Chemotherapy and Pharmacology · 2012 · 529 citations

Medicine, Oncology, Pharmacology +12

2-Deoxy-<scp>d</scp>-glucose Increases the Efficacy of Adriamycin and Paclitaxel in Human Osteosarcoma and Non-Small Cell Lung Cancers <b> <i>In Vivo</i> </b>

Gregory Maschek, Niramol Savaraj, Waldemar Priebe et al. · Cancer Research · 2004 · 444 citations

Medicine, Oncology, Pharmacology +17

Unusual retention of rhodamine 123 by mitochondria in muscle and carcinoma cells.

Ian C. Summerhayes, Théodore J. Lampidis, Samuel D. Bernal et al. · Proceedings of the National Academy of Sciences · 1982 · 371 citations · Full text

Life Sciences, Biochemistry, Oncology +7

Under normoxia, 2-deoxy-<scp>d</scp>-glucose elicits cell death in select tumor types not by inhibition of glycolysis but by interfering with N-linked glycosylation

Metin Kurtoğlu, Ningguo Gao, Jie Shang et al. · Molecular Cancer Therapeutics · 2007 · 244 citations

Life Sciences, Cell Biology, Oncology +17

Selective toxicity of rhodamine 123 in carcinoma cells in vitro.

Théodore J. Lampidis, Samuel D. Bernal, Ian C. Summerhayes et al. · PubMed · 1983 · 235 citations

Medicine, Oncology, Pharmacology +13